A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of Abiraterone Acetate (AB7630) Plus Prednisone in Patients with Metastatic Castration-Resistant Prostate Cancer Who Have Failed Docetaxel-Based Chemotherapy

  • Rinehart, John (PI)

Grants and Contracts Details

StatusFinished
Effective start/end date7/1/0810/30/08